Cargando…

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis

OBJECTIVE: The purpose of this study was to determine the pooled prevalence of vaccination willingness, unwillingness, and hesitancy among patients with multiple sclerosis. METHODS: Databases including PubMed, Scopus, EMBASE, Web of Science, and Google Scholar were searched. by two expert researcher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazdani, Amid, Mirmosayyeb, Omid, Ghaffary, Elham Moases, Hashemi, Mozhgan Sadat, Ghajarzadeh, Mahsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983030/ https://www.ncbi.nlm.nih.gov/pubmed/35381877 http://dx.doi.org/10.1007/s10072-022-06051-6

Ejemplares similares

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
por: Vaheb, Saeed, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2023)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Parkinson’s disease and COVID-19: a systematic review and meta-analysis
por: Khoshnood, Reza Jalili, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Neurosarcoidosis in an adult man with a family history of MS: A case report
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Vaccine hesitancy due to vaccine country of origin, vaccine technology, and certification
por: Dror, Amiel A., et al.
Publicado: (2021)

Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) Questionnaire
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

What is driving unwillingness to receive the COVID-19 vaccine in adult Bangladeshi after one year of vaccine rollout? Analysis of observational data
por: Ali, Mohammad
Publicado: (2022)

COVID-19 vaccine hesitancy among first-generation immigrants living in Sweden
por: Svallfors, Signe, et al.
Publicado: (2023)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

COVID-19 postvaccination adverse events and vaccine hesitancy among hospital employees: Is there a link?
por: Weiland, Anastasiia, et al.
Publicado: (2022)

Online misinformation and vaccine hesitancy
por: Garett, Renee, et al.
Publicado: (2021)

Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study
por: Bucyibaruta, Georges, et al.
Publicado: (2022)

SG-APSIC1026: COVID-19 vaccine acceptance and hesitancy among primary healthcare workers in Singapore
por: Koh, Sky Wei Chee, et al.
Publicado: (2023)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey
por: Noh, Yunha, et al.
Publicado: (2022)

Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia
por: Kaufman, Jessica, et al.
Publicado: (2022)

Factors influencing refugees’ willingness to accept COVID‐19 vaccines in Greater Sydney: a qualitative study
por: Mahimbo, Abela, et al.
Publicado: (2022)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Characteristics of COVID-19 disease in multiple sclerosis patients
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

Maternal vaccine hesitancy towards COVID-19 immunisation of children in Qatar: a population-based cross-sectional study
por: Reagu, Shuja, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge
por: D’Apolito, Maria, et al.
Publicado: (2023)

SG-APSIC1158: COVID-19 vaccine booster hesitancy among healthcare workers: A retrospective observational study in Singapore
por: Koh, Sky Wei Chee, et al.
Publicado: (2023)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis
por: Brecl Jakob, Gregor, et al.
Publicado: (2022)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
por: Habek, Mario
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ml5bas9403cv2lie0pgvlfg2mj